Breast Cancer
Studies in the area of breast cancer reported from N.J. Robert and co-researchers
Published in Medical Device Law Weekly, September 23rd, 2007
"In addition to knowing the hormone receptor status (estrogen and progesterone), human epidermal receptor 2 (HER2) should be evaluated. The measurement of this parameter is essential to optimizing the systemic management," wrote N.J. Robert and colleagues.
The researchers concluded: "This article reviews the biology of HER2, testing for HER2, clinical studies evaluating HER2-based therapies, side effects (specifically cardiotoxicity), and strategies for HER2-based...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Law Weekly
More Articles from Medical Device Law Weekly
- Biotech Business
Mintz Levin Represents Renowned Physician, Dr. Peter Rentrop, in Major Patent Infringement Victory - Acid Reflux Disease
Studies from Medical School in the area of acid reflux disease described - Acute Myelomonocytic Leukemia Genetics
Reports outline acute myelomonocytic leukemia genetics study results from University of Texas, M.D. Anderson Cancer Center - Alcoholism Risk Factors
Research from University of Ulsan, Department of Internal Medicine provides new data about alcoholism risk factors - Algorithms
Massachusetts General Hospital reports research in algorithms - Allergies
New allergies research from Hiroshima University, Medical Department outlined - More from this issue of Medical Device Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
